Other Regulatory Updates
Archived Updates
- The AST supports the founding of the recent bipartisan Senate NIH Caucus in a letter to Senators Richard Durbin (D-IL) and Lindsey Graham (R-SC).
- The Transplant Roundtable, made up of a group of organizations including the AST, submitted testimony on April 3, 2015 to support increased funding for the Division of Transplantation (DoT). Given the need for donor organs and the important programs administered by the DoT, the Transplant Roundtable requested an additional 3 million in funding: read the testimony for more details.
- Dr. Richard Formica presented a statement on behalf of the AST Board of Directors at the March 13, 2015 ACOT meeting; Rebecca Hays presented a statement on behalf of both the AST Board of Directors and the Live Donor Community of Practice (COP) at the same meeting
- View information on key messages about the ebola outbreak
- Interview forms optimized for obtaining medical history, behavioral risk, and travel information for a donor of organs and/or tissues are now available.
- AST recognized Congresswoman Lois Capps with the AST Transplant Advocacy Award for her years of crafting legislation that ultimately culminated in the HOPE Act.
- The Donation and Transplantation Community of Practice approved to increase the number of transplants each year by 1,000 over the next 5 years.
- NIH opens research hospital to outside scientists - new projects will enable non-government researchers to conduct clinical research.
- The Transplant Roundtable provided comments to the Centers for Medicare and Medicaid Services on Contract Year 2015 Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs.
- AST raised concerns regarding proposed rule to remove immuno medications as a protected class under Medicare C and D.
- AST raises concerns about plans to limit Medicare drug coverage.
- New clinical research network holds great promist for improving treatments for patients.
- September 24 & 25, 2013 - AST's Public Policy Committee descended on Capitol Hill to meet with more than a dozen Members of Congress to garner further support for federal NIH funding and medical research, and to strengthen support and cosponsors for the Transplant Patient Immunosuppressive Drug Coverage for Kidney Patients Act of 2013